IDEX Biometrics ASA
IDXAD
$0.001
$0.000.00%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -84.94% | 3.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -84.94% | 3.49% | |||
| Cost of Revenue | -87.98% | -1.69% | |||
| Gross Profit | -80.26% | 12.59% | |||
| SG&A Expenses | -26.59% | -19.63% | |||
| Depreciation & Amortization | -133.82% | 187.96% | |||
| Other Operating Expenses | -35.43% | -5.43% | |||
| Total Operating Expenses | -35.38% | 0.41% | |||
| Operating Income | 32.18% | -0.22% | |||
| Income Before Tax | 120.40% | -23.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 120.39% | -23.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 120.39% | -23.04% | |||
| EBIT | 32.18% | -0.22% | |||
| EBITDA | 21.60% | 14.98% | |||
| EPS Basic | 118.78% | -18.04% | |||
| Normalized Basic EPS | 93.01% | -18.18% | |||
| EPS Diluted | 118.78% | -14.50% | |||
| Normalized Diluted EPS | 93.01% | -21.19% | |||
| Average Basic Shares Outstanding | 7.42% | 4.29% | |||
| Average Diluted Shares Outstanding | 7.43% | 2.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
